Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 2/2011

01-04-2011 | Laboratory Investigation

Irreversible Electroporation in a Swine Lung Model

Authors: Damian E. Dupuy, Bassam Aswad, Thomas Ng

Published in: CardioVascular and Interventional Radiology | Issue 2/2011

Login to get access

Abstract

Purpose

This study was designed to evaluate the safety and tissue effects of IRE in a swine lung model.

Methods

This study was approved by the institutional animal care committee. Nine anesthetized domestic swine underwent 15 percutaneous irreversible electroporation (IRE) lesion creations (6 with bipolar and 3 with 3–4 monopolar electrodes) under fluoroscopic guidance and with pancuronium neuromuscular blockade and EKG gating. IRE electrodes were placed into the central and middle third of the right mid and lower lobes in all animals. Postprocedure PA and lateral chest radiographs were obtained to evaluate for pneumothorax. Three animals were sacrificed at 2 weeks and six at 4 weeks. Animals underwent high-resolution CT scanning and PA and lateral radiographs 1 h before sacrifice. The treated lungs were removed en bloc, perfused with formalin, and sectioned. Gross pathologic and microscopic changes after standard hematoxylin and eosin staining were analyzed within the areas of IRE lesion creation.

Results

No significant adverse events were identified. CT showed focal areas of spiculated high density ranging in greatest diameter from 1.1–2.2 cm. On gross inspection of the sectioned lung, focal areas of tan discoloration and increased density were palpated in the areas of IRE. Histological analysis revealed focal areas of diffuse alveolar damage with fibrosis and inflammatory infiltration that respected the boundaries of the interlobular septae. No pathological difference could be discerned between the 2- and 4-week time points. The bronchioles and blood vessels within the areas of IRE were intact and did not show signs of tissue injury.

Conclusion

IRE creates focal areas of diffuse alveolar damage without creating damage to the bronchioles or blood vessels. Short-term safety in a swine model appears to be satisfactory.
Literature
1.
go back to reference Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255:426–433CrossRefPubMed Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255:426–433CrossRefPubMed
2.
go back to reference Esser AT, Smith KC, Gowrishankar TR, Weaver JC (2007) Towards solid tumor treatment by irreversible electroporation: intrinsic redistribution of fields and currents in tissue. Technol Cancer Res Treat 6:261–274PubMed Esser AT, Smith KC, Gowrishankar TR, Weaver JC (2007) Towards solid tumor treatment by irreversible electroporation: intrinsic redistribution of fields and currents in tissue. Technol Cancer Res Treat 6:261–274PubMed
3.
go back to reference Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231CrossRefPubMed Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231CrossRefPubMed
4.
go back to reference Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R (2007) Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 6:313–320PubMed Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R (2007) Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 6:313–320PubMed
5.
go back to reference Edd JF, Davalos RV (2007) Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 6:275–286PubMed Edd JF, Davalos RV (2007) Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 6:275–286PubMed
6.
go back to reference Rabussay DP, Nanada GS, Goldfarb PM (2002) Enhancing the effectiveness of drug based cancer therapy by electroporation (electropermeabilization). Technol Cancer Res Treat 1:71–82PubMed Rabussay DP, Nanada GS, Goldfarb PM (2002) Enhancing the effectiveness of drug based cancer therapy by electroporation (electropermeabilization). Technol Cancer Res Treat 1:71–82PubMed
7.
go back to reference Goldberg SN, Dupuy DE (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities part 1. J Vasc Interv Radiol 12:1021–1032CrossRef Goldberg SN, Dupuy DE (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities part 1. J Vasc Interv Radiol 12:1021–1032CrossRef
8.
go back to reference McTaggart RA, Dupuy DE (2007) Thermal ablation of lung tumors. Tech Vasc Interv Radiol 10:102–113CrossRefPubMed McTaggart RA, Dupuy DE (2007) Thermal ablation of lung tumors. Tech Vasc Interv Radiol 10:102–113CrossRefPubMed
9.
go back to reference Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4:699–705PubMed Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4:699–705PubMed
10.
go back to reference Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P et al (2007) Tumor ablation with irreversible electroporation. PLoS ONE 2:e1135CrossRefPubMed Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P et al (2007) Tumor ablation with irreversible electroporation. PLoS ONE 2:e1135CrossRefPubMed
11.
go back to reference Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 4:295–300 Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 4:295–300
12.
go back to reference Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new modality clinical implications. Technol Cancer Res Treat 6:37–48PubMed Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new modality clinical implications. Technol Cancer Res Treat 6:37–48PubMed
13.
go back to reference Allegretti JP, Panje WR (2001) Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope 111:52–56CrossRefPubMed Allegretti JP, Panje WR (2001) Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope 111:52–56CrossRefPubMed
Metadata
Title
Irreversible Electroporation in a Swine Lung Model
Authors
Damian E. Dupuy
Bassam Aswad
Thomas Ng
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 2/2011
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-0091-9

Other articles of this Issue 2/2011

CardioVascular and Interventional Radiology 2/2011 Go to the issue